- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02457949
The Impact of Alternative Social Assistance Disbursement on Drug-related Harm (TASA)
The Impact of Alternative Social Assistance Disbursement on Drug-Related Harm: a Randomized Control Trial
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Coordinated monthly income assistance payments, while seeking to alleviate poverty, can also have negative and unintended impacts, particularly among people who use illicit drugs (PWUD). Observational research has identified escalations in drug-related harm coinciding with monthly assistance payments, such as overdose, treatment interruption, hospital admissions and public disorder. This project varies the timing and frequency of income assistance disbursement, and evaluates whether varying income assistance disbursement reduces drug-related harm coinciding with coordinated income assistance.
Conducted among 273 PWUD, participants will be allocated for 6 income assistance cycles to a control or one of two intervention arms. Participants in the control arm will receive payments according to the existing monthly government schedule. Participants in the intervention arm will receive their income assistance: (1) monthly on a day different from government cheque issue; or (2) semi-monthly on days different from government cheque issue. The intervention will be evaluated using qualitative and quantitative methods for its impact on drug use and related harms.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6Z 2A9
- British Columbia Centre on Substance Use
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- be ≥19 years of age or older
- reside in greater Vancouver, Canada
- report regular use of illicit drugs other than cannabis
- receive monthly provincial income assistance
- are not currently administered (where cheque issue/money is externally managed)
- be eligible and willing to be a client of the local credit union who will administer the intervention
- report intensified drug use around government cheque issue days
- provide written informed consent
- be willing to comply with study procedures
Exclusion Criteria:
- plan to relocate outside Vancouver
- have plans to discontinue income assistance
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Ingen indgriben: Treatment As Usual (TAU)
Receipt of social assistance on government cheque issue days for 6 income assistance cycles (approx 26 weeks).
|
|
|
Eksperimentel: Staggered Arm
Receipt of social assistance once monthly on a randomly assigned day that does not fall during the week of government cheque issue (Non-synchronized social assistance receipt), for 6 income assistance cycles (approx 26 weeks).
|
Social assistance disbursement outside government cheque issue week
Andre navne:
|
|
Eksperimentel: Staggered and Split Arm
Receipt of social assistance twice monthly on equally spaced randomly assigned days that do not fall during the week of government cheque issue (Non-synchronized social assistance receipt, cheque divided into two equal disbursements), for 6 income assistance cycles (approx 26 weeks).
|
Social assistance disbursement outside government cheque issue week
Andre navne:
Social assistance disbursement divided into two equal payments
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Illicit drug use on government cheque issue days
Tidsramme: 26 weeks
|
Timeline Follow Back (TLFB) assessed increase of drug use defined as an increase in the frequency of drug use of at least 40% or an increase in the number of drugs used during the 3 days beginning with government cheque issue day, compared to non-cheque issue days.
|
26 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Illicit drug use on non-government cheque issue days
Tidsramme: 26 weeks
|
Timeline Follow Back (TLFB) assessed increase of drug use defined as an increase in the frequency of drug use of at least 40% or an increase in the number of drugs used during the 3 days beginning with individual cheque issue day (among intervention participants), compared to non-cheque issue days.
|
26 weeks
|
|
Hospital admissions on government cheque issue days
Tidsramme: 26 weeks
|
Emergency Department, Emergency Department Mental Health and substance use hospitalizations in the three days beginning with government cheque issue day compared to non-cheque issue days.
|
26 weeks
|
|
Overdose
Tidsramme: 26 weeks
|
Self-reported non-fatal overdose and hospital record verified fatal overdose on the three days beginning with government cheque issue day compared to non-cheque issue days.
|
26 weeks
|
|
Police service utilization
Tidsramme: 26 weeks
|
Self-reported and police record-verified interactions with police or use of police services on the three days beginning with government cheque issue day compared to non-cheque issue days.
|
26 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Lindsey Richardson, DPhil, University of British Columbia
Publikationer og nyttige links
Generelle publikationer
- Richardson L, Laing A, Choi J, Nosova E, Milloy MJ, Marshall BD, Singer J, Wood E, Kerr T. Effect of alternative income assistance schedules on drug use and drug-related harm: a randomised controlled trial. Lancet Public Health. 2021 May;6(5):e324-e334. doi: 10.1016/S2468-2667(21)00023-2. Epub 2021 Apr 12.
- Mendell J, Richardson L. Integrated knowledge translation to strengthen public policy research: a case study from experimental research on income assistance receipt among people who use drugs. BMC Public Health. 2021 Jan 18;21(1):153. doi: 10.1186/s12889-020-10121-9.
- Richardson L, Laing A, Milloy MJ, Maynard R, Nosyk B, Marshall B, Grafstein E, Daly P, Wood E, Montaner J, Kerr T. Protocol of the impact of alternative social assistance disbursement on drug-related harm (TASA) study: a randomized controlled trial to evaluate changes to payment timing and frequency among people who use illicit drugs. BMC Public Health. 2016 Jul 29;16:668. doi: 10.1186/s12889-016-3304-6.
Hjælpsomme links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- H14-02401
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Stofbrug
-
Onconic Therapeutics Inc.Rekruttering
-
Seoul National University Bundang HospitalAktiv, ikke rekrutterendeDrug Drug Interaction (DDI)Sydkorea
-
Theravance BiopharmaAfsluttet
-
Astellas Pharma Europe B.V.AfsluttetSunde emner | Drug-Drug Interaction (DDI)Det Forenede Kongerige
-
Astellas Pharma Europe B.V.AfsluttetSunde emner | Farmakokinetik | Drug-Drug Interaction (DDI)Tyskland
-
Beijing Union Pharmaceutical Factory LtdIkke rekrutterer endnuDrug Drug Interaction (DDI)Kina
-
SPARK BiopharmaAfsluttetDrug Drug Interaction (DDI)Sydkorea
-
Allyx TherapeuticsNational Institute on Aging (NIA)Aktiv, ikke rekrutterendeDrug Drug Interaction (DDI)Forenede Stater
-
Astellas Pharma Europe B.V.AfsluttetSunde emner | Farmakokinetik | Drug-Drug Interaction (DDI)Tyskland
-
Beijing Continent Pharmaceutical Co, Ltd.Ikke rekrutterer endnuDDI (Drug-Drug Interaction) | Kronisk Hepatitis B LeverskleroseKina
Kliniske forsøg med Non-synchronized social assistance receipt
-
Alaine E Hernandez, PhDAmerican Music Therapy AssociationAfsluttetDemens | Telemedicin | Alder godtForenede Stater